Mycetoma: A Silent Suffering Demanding Health Equity and Sustainable Response

Mycetoma…a silent suffering that requires health justice and a sustainable response

Despite global medical progress, some neglected tropical diseases, such as mycetoma, still represent a major health challenge in developing countries. It is a chronic disease, one of the most dangerous skin infections that affects tissues and bones, and often leads to very serious pathological consequences if diagnosis and treatment are delayed.

From this standpoint,Earth Guards seeks to address the issue of mycetoma and its health and social repercussions from a comprehensive perspective, highlighting the relationship between health justice and sustainable development, and highlighting how international neglect of tropical diseases can lead to deepening inequalities among peoples; So they continuedReading.

What is mycetoma?

MycetomaMycetomais a chronic, contagious disease that attacks the tissues under the skin, and gradually expands to destroy deeper tissues and bones, leaving painful swellings and deformities. It is caused by various types of bacteria or fungi that penetrate the skin, often through thorns or small sharp objects.

The disease appears mainly in tropical and subtropical environments characterized by short rainy seasons and long droughts, which is an ideal environment for the growth of thorny shrubs, which are among the most prominent causes of skin infections that lead to the emergence of the disease. It is endemic in Africa, Asia, Latin America, and even parts of Europe.

The danger of mycetoma lies in delayed diagnosis, which leads to bone destruction, and in many casesIn cases, the affected limb must be amputated. What is worse is that patients – especially in poor areas – find only primitive local prosthetics that double their physical and psychological pain, and increase their social isolation.

Research and experiments

Despite limited funding and deteriorating infrastructure, the Mycetoma Research Center in Sudan continues its research performance in this regard, as it conducted a clinical trial for a new treatment that combats mycetoma disease, and it showed promising results that were published in the medical journal “The Lancet”.

According to the statements of Dr. Ahmed Hassan Fahal – Director of the Mycetoma Research Center at the University of Khartoum – environmental factors and living conditions play a fundamental role in the emergence of this disease, especially among farmers and children, which highlights the necessity of uniting global efforts to combatThis dangerous disease.

Surgery – in many late cases – remains the only solution despite its psychological consequences. Therefore, Dr. Borna Nyauk Anouk, head of the Myxoma Initiative, explains that surgery must be performed within the first six months of the disease’s history, but the delay in diagnosis and scarcity of resources makes patients reach stages where only amputation is feasible.

The head of the Myxoma Initiative also refers to the new clinical trial in which medications specifically used to treat tuberculosis have shown a response that reached 70% of cases. Which reduces the need for surgery. However, the lack of medicines and international support keeps patients stuck in a painful cycle of marginalization and helplessness.

WHO and Myostoma

On this disease, the WHO Regional Office for the East organizedOn June 16, the Mediterranean held a press conference in which mystoma was again highlighted after it was included in the list of neglected tropical diseases in 2016. The participants stressed the urgent need to support research and efforts to discover a suitable treatment, especially in the most affected countries such as Sudan, which is home to the only research center officially cooperating in this field with the World Health Organization.

Equitable Health Response

Mycetoma is not just a medical challenge, it is an expression of the health equity gap. It is a disease that exposes disparities in access to care, between those living in the heart of cities and those left on the margins of the world map. It is not possible to talk about equitable development or true sustainability as long as diseases such as mycetoma are neglected in this way.

Despite the challenges, the World Health Organization is strivingTo support research in this field – especially in cooperation with the Sudanese Center – and to enhance field awareness for workers in the health sector; In order to diagnose the disease early and reduce possible cases of amputation.

The organization also emphasizes that confronting mycetoma requires a comprehensive approach that includes prevention, improving living conditions, and supporting scientific research and innovation. These efforts are included within the plan to achieve universal health coverage by 2030, within the framework of the Sustainable Development Goals (SDGs), specifically the third goal on good health and well-being.

As stated above, this fungal tumor is one of the glaring paradoxes in today’s world. A world that possesses the technology and ability to develop complex vaccines within months, but silently ignores diseases that destroy the lives of thousands! The lack of funding and the lack of international interest in this disease represent a collective failure to achieve the most basic principles of justicehealth; Therefore, it is necessary to reconsider the priorities of medical and research investment, for the sake of equitable health security.